According to emerging trial results, there is evidence that a high dose of immunosuppressive therapy may induce sustained diminution of relapsing, hence, the remittance of multiple strains of sclerosis. This is an autoimmune disease caused when the immune system releases an attack against a human’s central nervous system. The long term effect is brain disorientation.
Five years into receiving the high dose of the immunosuppressive treatment therapy and autologous hematopoietic transplant of cells, a large percentage of the population, which adds up to 69%, managed to survive without the progressive experience of disability. According to the studies, the patients also did not experience relapsing symptoms of MS or re-emerging brain lesions. Most importantly, the patients did not take MS medications following the HDIT and HCT treatment. According to other studies, the available MS drugs are less effective.
MS symptoms vary from a motor, speech difficulties, fatigue, weakness and chronic pain. The primary common type of MS symptom is relapsing and remitting MS. It is usually characterized by differentiated periods of mild to no symptoms with flares of replaces. Over the past years, MS has worsened. According to trials and studies, it can become progressive.
Dr. Shiva Gopal’s Profile
Shiva Gopal is a neurologist by profession. He practices in Voorhees. He went to Government Medical College and graduated in the year 1979. His experience dates back forty years. He was a resident doctor at Boston City Hospital. Dr. Shiva Gopal also majors in psychiatry. Currently, he practices neurologist at Eastern Neurodiagnostic Associates. This is an affiliation of Kennedy Health of Systems Cherry Campus. He offers his services at insurance coverage including Aetna and Horizon Blue Cross. Dr. Shiva Gopal is a certified neurologist. Apart from being an English speaker, he speaks Spanish. Dr. Shiva Gopal is one of the thirty-four neurologists from Kennedy University Hospital. He is dedicated to offering neurological treatments by providing solutions to brain disorders.